User:Doc James/Sato

Current list of reviews/guidelines where Sato/Iwamoto reports are likely to affected results or interpretation 10/09/2018


 * 1) ✅  Doc James  (talk · contribs · email) 01:52, 11 September 2018 (UTC)
 * 2) ✅ Doc James  (talk · contribs · email) 02:02, 11 September 2018 (UTC)
 * 3) ✅ Doc James  (talk · contribs · email) 02:02, 11 September 2018 (UTC)
 * 4) ✅ Used but not in a concerning way Doc James  (talk · contribs · email) 02:02, 11 September 2018 (UTC)
 * 5) ✅ Used but not in a concerning way Doc James  (talk · contribs · email) 02:02, 11 September 2018 (UTC)
 * 6) ✅ Doc James  (talk · contribs · email) 02:02, 11 September 2018 (UTC)
 * 7) ✅ Doc James  (talk · contribs · email) 02:02, 11 September 2018 (UTC)
 * 8) ✅ Doc James  (talk · contribs · email) 02:02, 11 September 2018 (UTC)
 * 9) Currie L. Fall and Injury Prevention. 2008 [cited August 2015]. In: Patient Safety and Quality: An Evidence-Based Handbook for Nurses [Internet]. Rockville, MD: Agency for Healthcare Research and Quality. Available from: http://www.ncbi.nlm.nih.gov/books/NBK2653/.
 * 10) ✅ Doc James  (talk · contribs · email) 02:02, 11 September 2018 (UTC)
 * 11) ✅ Doc James  (talk · contribs · email) 02:02, 11 September 2018 (UTC)
 * 12) ✅ Doc James  (talk · contribs · email) 02:02, 11 September 2018 (UTC)
 * 13) ✅ Doc James  (talk · contribs · email) 02:02, 11 September 2018 (UTC)
 * 1) ✅ Doc James  (talk · contribs · email) 02:02, 11 September 2018 (UTC)
 * 2) ✅ Doc James  (talk · contribs · email) 02:02, 11 September 2018 (UTC)
 * 3) Currie L. Fall and Injury Prevention. 2008 [cited August 2015]. In: Patient Safety and Quality: An Evidence-Based Handbook for Nurses [Internet]. Rockville, MD: Agency for Healthcare Research and Quality. Available from: http://www.ncbi.nlm.nih.gov/books/NBK2653/.
 * 4) ✅ Doc James  (talk · contribs · email) 02:02, 11 September 2018 (UTC)
 * 5) ✅ Doc James  (talk · contribs · email) 02:02, 11 September 2018 (UTC)
 * 6) ✅ Doc James  (talk · contribs · email) 02:02, 11 September 2018 (UTC)
 * 7) ✅ Doc James  (talk · contribs · email) 02:02, 11 September 2018 (UTC)
 * 1) ✅ Doc James  (talk · contribs · email) 02:02, 11 September 2018 (UTC)
 * 2) ✅ Doc James  (talk · contribs · email) 02:02, 11 September 2018 (UTC)
 * 3) ✅ Doc James  (talk · contribs · email) 02:02, 11 September 2018 (UTC)
 * 1) ✅ Doc James  (talk · contribs · email) 02:02, 11 September 2018 (UTC)
 * 2) ✅ Doc James  (talk · contribs · email) 02:02, 11 September 2018 (UTC)
 * 1) ✅ Doc James  (talk · contribs · email) 02:02, 11 September 2018 (UTC)

Reports cited
12 identified Sato trial reports A1:Sato Y, Maruoka H, Oizumi K. Amelioration of hemiplegia-associated osteopenia more than 4 years after stroke by 1 alpha-hydroxyvitamin D3 and calcium supplementation. Stroke 1997;28:736-9.

A2:Sato Y, Honda Y, Kuno H, Oizumi K. Menatetrenone ameliorates osteopenia in disuse- affected limbs of vitamin D- and K-deficient stroke patients. Bone 1998;23:291-6.

A4:Sato Y, Manabe S, Kuno H, Oizumi K. Amelioration of osteopenia and hypovitaminosis D by 1alpha- hydroxyvitamin D3 in elderly patients with Parkinson&#39;s disease. J Neurol Neurosurg Psychiatry 1999;66:64-8.

A6:Sato Y, Honda Y, Kaji M, Asoh T, Hosokawa K, Kondo I, et al. Amelioration of osteoporosis by menatetrenone in elderly female Parkinson&#39;s disease patients with vitamin D deficiency. Bone 2002;31:114-8.

A19:Sato Y, Kanoko T, Satoh K, Iwamoto J. Menatetrenone and vitamin D2 with calcium supplements prevent nonvertebral fracture in elderly women with Alzheimer&#39;s disease. Bone 2005;36:61-8.

A17:Sato Y, Iwamoto J, Kanoko T, Satoh K. Risedronate therapy for prevention of hip fracture after stroke in elderly women. Neurology 2005;64:811-6.

A15:Sato Y, Iwamoto J, Kanoko T, Satoh K. Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke. Arch Intern Med 2005;165:1743-8.

A18:Sato Y, Kanoko T, Satoh K, Iwamoto J. The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial. Arch Intern Med 2005;165:1737-42.

A13:Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA 2005;293:1082-8.

A22:Sato Y, Iwamoto J, Kanoko T, Satoh K. Alendronate and vitamin D2 for prevention of hip fracture in Parkinson&#39;s disease: a randomized controlled trial. Mov Disord 2006;21:924-9.

A23:Sato Y, Honda Y, Iwamoto J. Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease. Neurology 2007;68:911-5.

A30:Sato Y, Iwamoto J, Honda Y. Once-weekly risedronate for prevention of hip fracture in women with Parkinson&#39;s disease: a randomised controlled trial. J Neurol Neurosurg Psychiatry 2011;82:1390-3.